INTRODUCTION
Colorectal cancer is an important public health problem in the Western world and the third leading cause of cancer-related death in the United States [1] . A total of 142,570 new colorectal cancer cases and 51,370 colon cancer-related deaths are expected in the United States in 2010 [2] .
A number of case-control and cohort studies have demonstrated an inverse relationship between the consumption of vegetables and colorectal cancer [3] . Among common vegetables selected on the basis of consumption per capita data in the United States, red chili pepper showed very high anti-proliferative and anti-oxidant activity [4] , and Americans' consumption of chili peppers has doubled to almost 6 pounds per capita per year since 1980 [5] .
Capsaicin is a major ingredient in hot chili pepper, and recent studies demonstrated anti-cancer activities of capsaicin in various types of cancer models [6] [7] [8] [9] [10] [11] [12] [13] . However, capsaicin also acts as a co-carcinogen or tumor promoter in some cancer models, including skin [14] and stomach [15] . Previously, we and others reported that capsaicin inhibits growth of colorectal cancer and tumor formation [6, 7, [16] [17] [18] [19] , and capsaicininduced apoptosis is mediated by various mechanisms including AMPK, caspase-3, PPAR, ROS, p53, TRPV6, EGFR/HER-2 and E2F [7] [8] [9] [10] [11] [12] [13] [18] [19] [20] [21] [22] .
A high incidence of human colorectal cancer has been associated with genetic alteration of either the β-catenin gene (CTNNB1) or the adenomatous polyposis coli (APC) gene, the products of which interact with casein kinase 1α, glycogen synthase kinase-3β (GSK-3β), and axin [23] . In the absence of Wnt stimulation, β-catenin is destabilized by phosphorylation and subsequent proteasomal degradation through 4 active GSK-3β. Free β-catenin accumulates in the cytoplasm and translocates into the nucleus, where it binds to the members of the T-cell factor (TCF) / lymphoid enhancer factor (LEF) family and transactivates several target genes, including cyclin D1 [24] , cmyc [25] , and PPAR-δ [26] . In particular, the formation of the β-catenin/TCF-4 complex results in a master switch that controls proliferation in malignant intestinal epithelial cells [27] . Therefore -catenin signaling is a significant target of chemoprevention by dietary compounds [28] [29] [30] .
The current study was performed to elucidate the mechanism by which capsaicin might prevent the growth of human colorectal cancer cells. Here, we report that capsaicin suppresses -catenin/TCF-dependent pathways through multiple mechanisms, including suppression of β-catenin transcription, activation of proteosomal degradation of β-catenin, and disruption of β-catenin/TCF-4 interactions in human colorectal cancer cells.
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MATERIALS AND METHODS
Materials
Capsaicin was purchased from BIOMOL (Plymouth Meeting, PA) and dissolved in absolute ethanol. Polyclonal antibody for β-catenin (#9562) and monoclonal antibody for TCF-4 (#2953) were purchased from Cell Signaling (Beverly, MA). Antibodies for cyclin D1 (sc-718), C/EBPα (sc-9315), ubiquitin (sc-8017) and actin (sc-1615) were purchased from Santa Cruz (Santa Cruz, CA). Antibody for GFP (130-091-833) was obtained from Miltenyi Biotec (Auburn, CA). MG-132, puromycin and cycloheximide were purchased from Calbiochem (San Diego, CA). The GFP-β-catenin expression vector, TOP/FOP FLASH luciferase constructs and cyclin D1 promoter were described previously [31, 32] .
Cell culture media were purchased from Invitrogen (Carlsbad, CA). All chemicals were purchased from Fisher Scientific, unless otherwise specified.
Cell culture and treatment
Human colorectal carcinoma cells (SW480, LoVo, and HCT-116) were purchased from American Type Culture Collection (Manassas, VA) and were grown at 37°C under a humidified atmosphere of 5% CO 2 . SW480, LoVo and HCT-116 cells were maintained in RPMI1640, Ham's F-12 and McCoy 5A media, respectively. All media were supplemented with 10% fetal bovine serum (FBS) and a mixture of penicillin (100 U/mL) and streptomycin (100 µg/mL). The cells were grown in 12-well plates (for luciferase analysis of TOP/FOP reporter gene, β-catenin or cyclin D1 promoter), 6-well plates (for overexpression of GFP-β-catenin) or 10 cm plates (for immunoprecipitation) at a concentration of 2x10 5 cells/mL and then treated with capsaicin at concentrations or time points indicated in figure legends. lysis buffer, and luciferase activity was determined and normalized to the pRL-null luciferase activity using a dual luciferase assay system (Promega) as we described previously [16, 33] .
2.4.Transient transfections
Western blotting
After three washes with ice-cold PBS, cells were scraped into an eppendorf tube and lysed with radioimmunoprecipitation assay (RIPA) buffer containing a protease/phosphatase inhibitors cocktail (Pierce). After centrifugation at 10,000xg for 10 min at 4°C, the supernatant was collected, and protein concentration was determined by the BCA protein assay (Pierce) using bovine serum albumin as a standard. The proteins were separated on SDS-PAGE and transferred to nitrocellulose membranes. The membranes were incubated with a specific primary antiserum in TBS containing 0.05%
Tween 20 (TSB-T) and 5% nonfat dry milk at 4°C overnight. After four washes with TBS-T, the blots were incubated with horse radish peroxidase-conjugated IgG for 1 h at room temperature and visualized using ECL (Amersham Biosciences, Piscataway, NJ).
Immunoprecipitation
Cells were lysed using M-PER mammalian protein extraction reagent (Thermo Scientific, Rockford, IL) for 30 m and then centrifuged for 5 m at 10,000xg at 4°C. The supernatants were incubated with polyclonal anti-β-catenin antibody (1:100) overnight at 4°C, followed by incubation with protein A/G beads (Santa Cruz) for 2 h at 4°C. After washing four times in ice-cold PBS, the protein complex was boiled in an equal volume of 2X SDS-sample buffer and used for immunoblotting using monoclonal anti-ubiquitin or monoclonal anti-TCF-4 antibody.
Preparation of nuclear extracts
The cells were plated onto a 10 cm culture dish and treated with capsaicin. Nuclear extracts were harvested using the Nuclear Extract Kit (Active Motif, Carlsbad, CA), according to the manufacturers' protocol. 
Isolation and analysis of RNA
Statistical analysis
Statistical analysis was performed with the Student t test, with statistical significance set at *, P < 0.05; **, P < 0.01; ***, P < 0.001.
RESULTS
Inhibitory effects of capsaicin on growth of colorectal cancer cells
To investigate whether capsaicin possessed anti-proliferative activity in APC mutant human colorectal cancer cells, SW480 and LoVo cells (APC mutant, β-catenin wild type) were exposed to 0, 50 and 100 µM of capsaicin for 0, 1, 2, or 3 d, and cell proliferation was performed as described in Materials and Methods. We also measured anti-proliferative activity of capsaicin in HCT-116 cells (APC wild type, β-catenin mutant).
As shown in Fig. 1 , growth of all three human colorectal cancer cell lines was inhibited by capsaicin treatment in a dose-and time-dependent manner. Although 50 µM capsaicin treatment decreased cell growth to some extent, significantly retarded cell growth was observed in cells treated with 100 µM of capsaicin. In addition, these data indicated that cell growth arrest by capsaicin exposure was mediated in an APCindependent manner.
Decreased transcriptional activity of β-catenin by capsaicin treatment
Alteration of β-catenin signaling caused by mutation in the APC or CTNNB1 gene is associated with colorectal tumorigenesis [34] . In order to determine whether capsaicin modulated -catenin/TCF-dependent activity, a luciferase reporter assay was performed using TOP-FLASH or FOP-FLASH constructs containing six copies of wild type or mutated TCF binding sites, respectively. Capsaicin treatment significantly inhibited the TOP/FOP ratio in a dose-dependent manner, in cells treated with 50 and 100 µM of capsaicin for 48 h (Fig. 2 ). These findings indicated that capsaicin suppressed β-catenin/TCF-dependent signaling in human colorectal cancer cells. It is also expected that nuclear translocation of β-catenin is positively associated with transcriptional activity of β-catenin. To define whether capsaicin alters nuclear localization, we performed Western blot from fractionated nuclear or cytosolic lysates after 48 h capsaicin treatment. The result shows that capsaicin treatment in SW480 cells did not alter nuclear translocation of endogenous ( Fig. 4A ) and ectopically transfected β-catenin (Fig. 4C) . Instead, capsaicin treatment decreased β-catenin protein level in both fractions (nucleus and cytosol). This trend was also observed in LoVo cells (Fig. 4B, D) . Isolation of nuclear and cytosol proteins was validated by the expression of C/EBPα, which is expressed only in the nucleus. It is notable that ectopically expressed β-catenin was mainly localized in the cytosol fraction (Fig. 4C, D) . 
Decreased expression of β-catenin by capsaicin treatment
Transcriptional down-regulation of the β-catenin gene by capsaicin in SW480 cells
To investigate the possible molecular mechanism of capsaicin in down-regulation of β-catenin, SW480 cells were incubated with 0, 50, or 100 µM of capsaicin, and mRNA levels of β-catenin were measured using RT-PCR. The result revealed a dosedependent decrease in transcript levels of β-catenin after capsaicin treatment (Fig. 5A ).
We also observed a significant decrease of cyclin D1 mRNA in the cells treated with as cyclin D1 [24] . Thus, to test whether capsaicin affects transcriptional activity of the cyclin D1 gene, we measured luciferase activities of cyclin D1 promoter containing -163 and +130, which contains the TCF binding site [35] . Capsaicin treatment resulted in a dose-dependent decrease of cyclin D1 promoter activity, greater than that seen for Catnb (Fig. 5C ). Together with results of Fig. 3(D, E) , these data imply that downregulation of cyclin D1 transcription is independent of β-catenin down-regulation.
We also compared cell viability to see whether decreased promoter activity is a result of cell death. As shown in Fig. 5D , cell viability decreased 9% and 17% in the cells treated with 50 and 100 µM of capsaicin, respectively. The decreased cell viability seems to be a result of activated apoptosis because we and others observed that capsaicin induces apoptosis in human colorectal cancer cells [7-13, 16, 18-22] .
However, decreased rate of cell viability (9 and 17%) is much less than those of promoter activities of β-catenin (16 and 41%) or cyclin D1 promoter (32 and 74%),
implying that decreased promoter activity represents transcriptional down-regulation of β-catenin and cyclin D1.
Proteosomal degradation of β-catenin by capsaicin
β-catenin becomes stabilized when proteasome-mediated proteolysis is inhibited, and this leads to the accumulation of multi-ubiquitinated forms of β-catenin [36] . Thus, we tested whether proteasomal degradation contributes to the decrease of β-catenin protein levels using the proteasome inhibitor MG-132. Pre-treatment with MG-132 diminished capsaicin-mediated down-regulation of β-catenin in SW480 and LoVo cells (Fig. 6A, B) . Next, to confirm this data, we compared β-catenin protein levels after capsaicin treatment in the presence of the protein synthesis inhibitor cycloheximide (CHX). GFP-tagged β-catenin expression vector was transfected into SW480 cells and the cells were co-treated with CHX and capsaicin for indicated times. As shown in Fig.   6C , degradation of β-catenin occurred more rapidly in the presence of capsaicin. This more rapid degradation of β-catenin by capsaicin treatment was also observed in LoVo cells (data not shown). These results suggest that capsaicin suppresses β-catenin expression at both transcriptional and post-translational levels.
It is well established that β-catenin is degraded by the 26S proteasome after the covalent binding with ubiquitin [23] . To confirm that the reductions in β-catenin levels by capsaicin treatment are indeed caused by this mechanism, we tested whether capsaicin treatment results in an increase of ubiquitinated β-catenin levels. The results show that appearance of an ubiquitin immunoreactive β-catenin band is increased by the addition of capsaicin ( Fig. 6D and E) . In reflecting decreased immunoprecipitated β-catenin in response to capsaicin, it seems likely that the β-catenin-conjugated ubiquitination was increased significantly by capsaicin treatment. As shown in Fig. 6E (right panel)
normalizing amounts of immunoprecipitated β-catenin in immunoprecipitation step revealed a more dramatic increase in ubiquitinated bands on the immunoblots.
Capsaicin decreased TCF-4 expression and binding of β-catenin to TCF-4
Another possible mechanism regulating transcriptional activity of β-catenin is integrity of the β-catenin/TCF complex, which is required for normal transcriptional activity. Because cellular levels of β-catenin protein expression remained unchanged in HCT-116 cells (Fig. 3C ), despite suppressed transcriptional activity of β-catenin ( Fig.   2C ), we examined the possibility that capsaicin disrupts the association of β-catenin with TCF-4. For this, cell lysates were pulled down with β-catenin and immunoblotted with anti-TCF-4 antibody. As a result, a substantial level of β-catenin is associated with TCF-4 in vehicle-treated cells: however, capsaicin treatment abolished the association between β-catenin and TCF-4 in all three human colorectal cancer cells (Fig. 7A , B, C).
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We also sought to determine the changes of TCF-4 expression after capsaicin treatment. As shown in Fig. 7 (D, E, F), TCF4 expression was decreased by capsaicin treatment in human colorectal cancer cells. This result indicates that the capsaicinmediated decrease of TCF-4 expression blocks the β-catenin-TCF4 interaction.
DISCUSSION
Hot chili red peppers are among the most heavily and frequently consumed spices.
Capsaicin found in these peppers has been subjected to extensive experimental and clinical investigations due to its prominent pharmacologic and toxicological properties [37] . In a previous study, we observed that capsaicin treatment significantly induced growth arrest and apoptosis of human colorectal cancer cells [16] . However, the underlying mechanisms by which capsaicin affects human colorectal carcinoma have been only partially determined.
Deregulation of β-catenin/TCF-dependent signaling is an important event in the development of various malignancies, including colorectal and other types of cancer. In most colorectal cancer cells, the β-catenin/TCF pathway is constitutively active at a high level due to defective APC or β-catenin genes and plays a crucial role in the progression of a subset of these cancers, suggesting an important target in the control of cellular proliferation or cell death. Therefore, we focused on β-catenin expression as an anti-proliferative target of capsaicin. For the first time, our data reveal that expression of β-catenin is suppressed by capsaicin treatment in APC mutant human colorectal cancer cells in which the β-catenin pathway is active.
In this study, we observed that capsaicin down-regulates β-catenin transcription as well as protein stability. Simultaneous transcriptional and post-translational modulation of β-catenin has been reported previously by other research groups. Treatment with indomethacin or activation of cGMP-dependent protein kinase in human colorectal cancer cells suppressed β-catenin expression via transcriptional as well as posttranslational modification [38, 39] . Although marked increases in the levels of mRNA and promoter activity of the CTNNB1 gene were found in the carcinomas compared with the non-neoplastic mucosa [40] [41] [42] , very little data looks at the regulation of β-catenin expression at the transcriptional level. In this report, we found that capsaicin reduced β-catenin expression through down-regulation of β-catenin mRNA expression in SW480 cells (Fig. 5) . The promoter region of the gene encoding the -catenin protein contains binding sites for several important transcription factors, in human, rat, and mouse [43] .
Protein/DNA array analyses identified several of these transcription factors for the rat Ctnnb1 promoter, including E2F1, NFkB, MEF1, Smad3/4, and GATA [43] . So, mechanistic studies for transcriptional down-regulation of the β-catenin gene by capsaicin are required in the future. β-catenin mRNA was decreased by 40% and 60%
whereas promoter activity was decreased by 16% and 41% in 50 and 100 µM capsaicin-treated cells, respectively (Fig. 5A, B) . The reason of discrepancy between mRNA and promoter activity is probably that capsaicin affects β-catenin mRNA stability or that the promoter used in this study may not contain all the necessary regulatory elements for β-catenin transcription.
In addition to transcriptional down-regulation, we observed that capsaicin treatment enhanced β-catenin degradation, which is associated with increased ubiquitination of β-catenin (Fig. 6 ). Since SW480 and LoVo cells contain a mutated APC gene that encodes for a truncated APC protein [44] , it is likely that suppression of β-catenin by capsaicin is accomplished via APC-independent, proteasome-mediated pathways [38, 45, 46] .
Interestingly, in HCT-116 cells (APC wild type, β-catenin mutant) we observed significant suppression of β-catenin transcriptional activity (Fig. 2C) without reduction of the β-catenin level (Fig. 3C) or alteration of β-catenin distribution between the nucleus and cytosol (data not shown) upon treatment with capsaicin. This rules out the possibility that the capsaicin interference with -catenin/TCF-dependent transcription is mediated by regulating the total amount of β-catenin and/or its cellular distribution. Thus, we tested the possibility that other molecules associated with regulation of β-catenin transcriptional activity may be altered under the influence of capsaicin. As a result, we observed that capsaicin suppressed TCF-4 expression and disrupted protein-protein interaction between β-catenin and TCF-4 in HCT-116 cells (Fig. 7) . Thus, the possible explanation for discrepancy between impaired transcriptional activity and no alteration of β-catenin is that capsaicin directly inhibits TCF-4 expression and interferes with the formation of a transcriptionally active complex between β-catenin and TCF-4. Because TCF-4 has been shown to be constitutively activated by mutated β-catenin and induction of the pro-apoptotic pathway directly leads to the reduction of TCF-4 mRNA and protein levels [47] , TCF-4 could be a therapeutic target for anti-cancer drugs. One aspect remaining unresolved in this study is the detailed mechanism of how capsaicin down regulates TCF-4 expression. This needs to be elucidated in a future study. (Fig 3D,E) . In this study, we also observed that TCF-4 was decreased at 24 h after capsaicin treatment, earlier than β-catenin ( Fig. 7D-F ) and transcriptional activity of β-catenin is suppressed in the cells treated with 100 µM of capsaicin for 24 h (data not shown). Taken together, these data indicate that the decrease of TCF-4 by capsaicin treatment is more likely responsible than β-catenin loss for suppression of transcriptional activity of β-catenin/TCF-driven gene expression such as cyclin D1. However, we do not exclude the possibility that reduction of cyclin D1
could be a consequence of multiple mechanisms including proteasome degradation because cyclin D1 is a target of proteasomal degration by various compounds including 6-gingerol [32] , curcumin [50] , retinoic acid [51] , and troglitazone [52] . Although we did not compare cell cycles in this study, it has been reported that capsaicin results in sustained suppression of cyclin D1 levels and consequently the inhibition of G1 to S transitions [10] [11] [12] .
The concentration used in this study (100 µM) is equivalent to those used in several other studies using human colorectal cancer cells in vitro [7, 17, 18] . We do not know the exact physiological concentration of capsaicin and effective in vivo dose to suppress colon cancer in humans. There is much concern that concentration used in in vitro are relevant in vivo. Thus, prediction of relevant in vitro doses should be considered with couples of factors including bioavailability, potential active metabolites and local concentration.
Vanilloid receptor-1 (VR-1) is a well known receptor of capsaicin and mediates capsaicin's biological roles including anti-cancer activity [53] . Capsaicin is also known to mediate apoptosis through a PPAR-dependent pathway [19] , which also downregulates cyclin D1 expression [54] . Because we observed that human colorectal cancer cells express VR-1 and capsaicin is a ligand of PPARγ (data not shown), we tested whether capsaicin-mediated β-catenin suppression is mediated by these two pathways by treatment of cells with selective inhibitors against VR-1 (capsazepine;CPZ)
or PPAR (GW9662). The result indicated that capsaicin down-regulates β-catenin and cyclin D1 via a VR-1-and PPAR-independent pathway (data not shown), consistent with other studies reporting no association between VR-1 or PPAR and capsaicinmediated carcinogenesis [14, 19, 55] . However, Kim et al. (2004) claimed that capsaicin-induced apoptotic cell death is mediated by the PPAR pathway in HT-29
human colorectal cancer cells [19] . Discrepancy between PPAR-dependent apoptosis and independent β-catenin suppression is not clearly demonstrated, but it is likely due to differences of cell type and study context. Nuclear and cytosol fractions were isolated and Western blot was performed using GFP, C/EBPα and actin antibodies. 
